Octagon Capital Advisors »

Praxis Precision Medicines I shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $11M 260k 41.36
2024-03-31 $16M 260k 61.02

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Structure Therapeutics Sponsored Ads (GPCR)
Dyne Therapeutics (DYN)
Arrivent Biopharma (AVBP)
Verona Pharma Sponsored Ads (VRNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)
Ocular Therapeutix (OCUL)
Perspective Therapeutics Com New
Mind Medicine Mindmed Com New (MNMD)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Octagon Capital Advisors

Top funds holding Praxis Precision Medicines I

Adage Capital Partners GP
BlackRock
RA Capital Management
Point72 Asset Management
Vanguard Group
T. Rowe Price Associates
State Street Corporation
Perceptive Advisors
Verition Fund Management
VR Adviser
Cormorant Asset Management
Soleus Capital Management
Partner Fund Management
FMR
Vestal Point Capital

View all funds holding Praxis Precision Medicines I